Skip to main content

Physician Behind Surgisphere Scandal Switches Medical Licenses

Sapan Desai has inactivated his license in Illinois, where multiple malpractice lawsuits against him are pending, and obtained a new one in Ohio.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: ISTOCK.COM, ANDREI_R

Update (November 2): Sapan Desai has requested that his newly obtained Ohio medical license be inactivated, according to documents obtained by The Scientist. In correspondence sent a few days after this story was published, Desai wrote to the State Medical Board of Ohio that he would “not be practicing medicine in the state of Ohio.”

Sapan Desai, the embattled vascular surgeon and CEO of the now-defunct Surgisphere Corporation, has inactivated his medical license in one state and obtained a license in another.

Each US state has its own licensing board, and generally a doctor requires an in-state license to practice medicine there—although Illinois is one of many states that is granting emergency authorization to some out-of-state physicians in response to the COVID-19 crisis, provided they have an active license and are in good standing.

According to public records held by the Illinois Department of Financial and Professional ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
Related articles background image
July digest cover
July 2026

Polyacrylamide Gels Turn into Mini Sculptures

Instead of discarding used polyacrylamide gels, biochemist Palina Kot reshapes them into artworks that reflect the realities of scientific research.

View this Issue
Make NGS Your BFF With Lunatic

Make NGS Your BFF With Lunatic

Unchained Labs
Scaling Human AT2 Cell Isolation for Translational Lung Research

Scaling Human AT2 Cell Isolation for Translational Lung Research

Miltenyi
Interpreting CRISPR Screens Through Protein-Level Biology

Interpreting CRISPR Screens Through Protein-Level Biology

Nomic Bio

Products

A top-down view of an open cardboard box

Introducing the Responsible Pipette Tip Box: Sartorius Light Pack

sartorius logo
tecan logo

Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA

Leica Biosystems Logo

Versant Diagnostics Expands Collaboration with Leica Biosystems as PRW Laboratories Becomes First to Deploy Aperio GT Elite Solution

Cenevo Logo

HighRes® and Cenevo Announce Co-Marketing Partnership to Accelerate the Agentic Connected Lab